Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sean M Devlin

Showing results (1-10 of 173) with videos related to

Pageof 18
Sort By:
Blood Cancer Discovery|December 4, 2024
Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A RoadmapOla Landgren, Sean M Devlin
Contemporary Clinical Trials|December 6, 2022
Deconstructing the Kaplan-Meier curve: Quantification of treatment effect using the treatment effect processSean M Devlin, John O'Quigley
Statistical Methods in Medical Research|December 10, 2020
Concordance probability as a meaningful contrast across disparate survival timesSean M Devlin, Glenn Heller
Journal of the Royal Statistical Society. Series C, Applied Statistics|January 14, 2025
Measuring the impact of new risk factors within survival modelsGlenn Heller, Sean M Devlin
Human Heredity|July 26, 2017
Statistical Interactions from a Growth Curve PerspectiveSean M Devlin, Jaya M Satagopan
Plos Computational Biology|November 9, 2021
Identifying prognostic pairwise relationships among bacterial species in microbiome studiesSean M Devlin, Axel Martin, Irina Ostrovnaya
Statistical Methods in Medical Research|December 24, 2021
Stopping rules for phase I clinical trials with dose expansion cohortsSean M Devlin, Alexia Iasonos, John O'Quigley
Biometrics|January 13, 2016
Boomerang: A method for recursive reclassificationSean M Devlin, Irina Ostrovnaya, Mithat Gönen
Lifetime Data Analysis|July 26, 2020
Measuring the temporal prognostic utility of a baseline risk scoreSean M Devlin, Mithat Gönen, Glenn Heller
Journal of the Royal Statistical Society. Series C, Applied Statistics|August 26, 2022
Phase I clinical trials in adoptive T-cell therapiesSean M Devlin, Alexia Iasonos, John O'Quigley
Pageof 18

Showing results (1-10 of 173) with videos related to

Sort By:
Pageof 18
Blood Cancer Discovery|December 4, 2024
Minimal Residual Disease as an Early Endpoint for Accelerated Drug Approval in Myeloma: A RoadmapOla Landgren, Sean M Devlin
Contemporary Clinical Trials|December 6, 2022
Deconstructing the Kaplan-Meier curve: Quantification of treatment effect using the treatment effect processSean M Devlin, John O'Quigley
Statistical Methods in Medical Research|December 10, 2020
Concordance probability as a meaningful contrast across disparate survival timesSean M Devlin, Glenn Heller
Journal of the Royal Statistical Society. Series C, Applied Statistics|January 14, 2025
Measuring the impact of new risk factors within survival modelsGlenn Heller, Sean M Devlin
Human Heredity|July 26, 2017
Statistical Interactions from a Growth Curve PerspectiveSean M Devlin, Jaya M Satagopan
Plos Computational Biology|November 9, 2021
Identifying prognostic pairwise relationships among bacterial species in microbiome studiesSean M Devlin, Axel Martin, Irina Ostrovnaya
Statistical Methods in Medical Research|December 24, 2021
Stopping rules for phase I clinical trials with dose expansion cohortsSean M Devlin, Alexia Iasonos, John O'Quigley
Biometrics|January 13, 2016
Boomerang: A method for recursive reclassificationSean M Devlin, Irina Ostrovnaya, Mithat Gönen
Lifetime Data Analysis|July 26, 2020
Measuring the temporal prognostic utility of a baseline risk scoreSean M Devlin, Mithat Gönen, Glenn Heller
Journal of the Royal Statistical Society. Series C, Applied Statistics|August 26, 2022
Phase I clinical trials in adoptive T-cell therapiesSean M Devlin, Alexia Iasonos, John O'Quigley
Pageof 18